Corneal changes in diabetes mellitus

Current Diabetes Reviews

Volumn 8, Issue 4, 2012, Pages 294-302

  Bikbova, Guzel ^a   Oshitari, Toshiyuki ^a   Tawada, Ayako ^a   Yamamoto, Shuichi ^a  

^a CHIBA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Advanced glycation end products; Corneal wound healing; Diabetes mellitus; Endothelial cell dysfunction; Epithelial defect; Growth factors; Neurotrophic keratopathy; Vitrectomy

Indexed keywords

ADVANCED GLYCATION END PRODUCT; AMINOGUANIDINE; ANTIBIOTIC AGENT; ARTIFICIAL TEAR; COLLAGEN FIBER; CORTICOSTEROID; FIDARESTAT; INSULIN;

APOPTOSIS; CENTRAL CORNEAL THICKNESS; CLINICAL FEATURE; CORNEA; CORNEA CELL; CORNEA DISEASE; CORNEA EDEMA; CORNEA EPITHELIUM; CORNEA INJURY; CORNEA THICKNESS; CROSS LINKING; DIABETES MELLITUS; DIABETIC KERATOPATHY; DIABETIC RETINOPATHY; ENDOTHELIAL CELL DYSFUNCTION; ENDOTHELIAL DYSFUNCTION; GENE THERAPY; HUMAN; KERATOMILEUSIS; KERATOPATHY; NONHUMAN; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PENETRATING KERATOPLASTY; PRIORITY JOURNAL; REVIEW; SLIT LAMP; TISSUE ENGINEERING; VISUAL IMPAIRMENT;

AGE DISTRIBUTION; CORNEA; CORNEAL DISEASES; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; DIABETIC RETINOPATHY; ENDOTHELIAL CELLS; FEMALE; GLYCOSYLATION END PRODUCTS, ADVANCED; HUMANS; MALE; PREDICTIVE VALUE OF TESTS; RISK FACTORS; SEVERITY OF ILLNESS INDEX; TIME FACTORS;

EID: 84862599957     PISSN: 15733998     EISSN: 18756417     Source Type: Journal    
DOI: 10.2174/157339912800840479     Document Type: Review

References (112)

1. Resnikoff S, Pascolini D, Etya'ale D, et al. Global data on visual impairment in the year 2002. Bull World Health Organization 2004; 11: 844-51.
2. Kempen J, O'Colmain B, Leske M, et al. Eye diseases prevalence research group. The prevalence of diabetic retinopathy among adults in the United States. Arch Ophthalmol 2004; 4: 552-63.
3. Saaddine J, Honeycutt A, Narayan K, et al. Projection of diabetic retinopathy and other major eye diseases among people with diabetes mellitus: United States, 2005-2050. Arch Ophthalmol 2008; 12: 1740-47.
4. Chu J, Ali Y. Diabetic Retinopathy. Drug Deve Res 2008; 69: 1-14.
5. Wild S, Roglic G, Greene A. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 2004; 27: 1047-53.
6. Oshitari T and Roy S. Diabetes: a potential enhancer of retinal injury in rat retinas. Neurosci Lett 2005; 390: 25-30.
7. Oshitari T, Yamamoto S, Hata N, Roy S. Mitochondria- and caspase-dependent cell death pathway involved in neuronal degeneration in diabetic retinopathy. Br J Ophthalmol 2008; 92: 552-6.
8. Oshitari T and Roy S. Common therapeutic strategies for the diabetic retinopathy and glaucoma. Curr Drug Ther 2007; 2: 224-32.
9. Oshitari T, Hata N, Yamamoto S. Endoplasmic reticulum stress and diabetic retinopathy. Vask Health Risk Manag 2008; 4: 115-22.
10. Oshitari T, Hata N, Yamamoto S. Effect of neurotrophic factors on neuronal apoptosis and neurite regeneration in cultured rat retinas exposed to high glucose. Brain Res 2010; 1346: 43-51.
11. Krachmer J, Mannis M, Holland E. Eds. Cornea. fundamentals, diagnosis, and management. 3rd ed. St. Louis: Mosby Elsevier 2011.
12. Schwartz D. Corneal sensitivity in diabetics. Arch Ophthalmol 1974; 91: 174-8.
13. Armaly M, Baloglou P. Diabetes mellitus and the eye: Changes in the anterior segment. Arch Opthalmol 1967; 77: 485-92.
14. Saghizadeh M, Kramerov A, Yu F, Castro M, Ljubimov A. Normalization of Wound Healing and Diabetic Markers in Organ Cultured Human Diabetic Corneas by Adenoviral Delivery of c-Met Gene Invest Ophthalmol Vis Sci 2010; 51: 1970-80.
15. Kim J, Kim C, Sohn E, Kim Y, Kim J. Involvement of advanced glycation end products, oxidative stress and nuclear factor-kappa B in the development of diabetic keratopathy. Graefes Arch Clin Exp Ophthalmol 2011; 249: 529-36.
16. Cobo L, Hatchell D. Treatment of severe diabetic keratopathy with a topical aldose reductase inhibitor: clinical response and electron microscopy. Invest Ophthalmol Vis Sci 1980; 26: 176. [ARVO Abstract].
17. Fukushi S, Merola L, Tanaka M. Reepithelialization of denuded corneas in diabetic rats. Exp Eye Res 1980; 31: 611-21.
18. Murata T, Ishibashi T, Nagai R, Horiuchi S, Amano S Advanced glycation end products in diabetic corneas. Invest Ophthalmol Vis Sci 2000; 41: 362-8.
19. Yucel I, Yucel G, Akar Y, et al. Transmission electron microscopy and autofluorescence findings in the cornea of diabetic rats treated with aminoguanidine. Can J Ophthalmol 2006; 41: 60-6.
20. Kaji Y, Amano S, Usui T, et al. Expression and function of receptors for advanced glycation end products in bovine corneal endothelial cells. Invest Ophthalmol Vis Sci 2003; 44: 521-8.
21. Kasper M, Roehlecke C, Witt M, et al. Induction of apoptosis by glyoxal in human embryonic lung epithelial cell line L132. Am J Respir Cell Mol Biol 2000; 23: 485-91.
22. Brownlee M. Advanced protein glycosylation in diabetes and aging. Annu Rev Med 1995; 46: 223-34.
23. Sady C, Khosrof S, Nagaraj R. Advanced Maillard reaction and crosslinking of corneal collagen in diabetes. Biochem Biophys Res Commun 1995; 214: 793-7.
24. Araki N, Ueno N, Chakrabarti B, Morino Y, Horiuchi S. Immunochemical evidence for the presence of advanced glycation end products in human lens proteins and its positive correlation with aging. J Biol Chem 1992; 267: 10211-4.
25. Marion M, Carlson E. Immunoelectron microscopic analyses of Maillard reaction products in bovine anterior lens capsule and Descemet's membrane. Biochim Biophys Acta 1994; 1191: 33-42.
26. Kase S, Ishida S, Rao N. Immunolocalization of advanced glycation end products in human diabetic eyes: an immunohistochemical study. J Diabetes Mellit 2011; 3: 57-62.
27. Gul M, Emre S, Esrefoglu M, Vard N. Protective effects of melatonin and aminoguanidine on the cornea in streptozotocininduced diabetic rats. Cornea 2008; 27: 795-801.
28. Herse PR. Corneal hydration control in normal and alloxan-induced diabetic rabbits. Invest Ophthalmol Vis Sci 1990; 31: 2205-13.
29. Weston B, Bourne W, Polse K, Hodge D. Corneal hydration control in diabetes mellitus. Invest Ophthalmol Vis Sci 1995; 36: 586-95.
30. Hasan S. Chapter 12: Cornea in Diabetes Mellitus In: Browning D, Eds. Diabetic Retinopathy: Evidence-based management. New York: Springer 2010; pp. 347-51.
31. Yu L, Chen X, Qin G, Xie H, Lv P. Tear film function in type 2 diabetic patients with retinopathy. Ophthalmologica 2008; 222: 284-91.
32. Alves M, Carvalheira J, Mydulo C, Rocha E. Tear film and ocular surface changes in diabetes mellitus. Arq Bras Oftalmol 2008; 71: 96-103.
33. Göbbels M, Spitznas M, Oldendoerp J Impairment of corneal epithelial barrier function in diabetics Graeffes Archives of Clin Exp Ophthalmology 1989; 2: 142-4.
34. Kenyon K, Watai Z, Michels R, Conway B, Tolentino. Corneal basement membrane abnormalities in diabetes mellitus. Invest Ophthalmol Vis Sci 1978; 17: 245.
35. Azar D, Spurr-Michaud S, Tisdale A, Gipson I. Decreasedpenetration of anchoring fibrils into the diabetic stroma. A morphometric analysis. Arch Ophthalmol 1989; 107: 1520-1523.
36. Ljubimov A, Huang Z, Huang G, et al. Human Corneal Epithelial Basement Membrane and Integrin Alterations in Diabetes and Diabetic Retinopathy J Histochem Cytochem 1998; 46: 1033.
37. Quadrado M, Popper M, Morgado A, Murta J, Van Best J. Diabetes and corneal cell density in humans by in vivo confocal microscopy. Cornea 2006; 25: 761-8.
38. Rosenberg M, Tervo T, Immonen I, Muller L, Gronhagen-Riska C, Vesaluoma M. Corneal Structure and Sensitivity in Type 1Diabetes Mellitus. Invest Ophthalmol Vis Sci 2000; 41: 2915-21.
39. Claramonte P, Ruiz-Monero J, Sánchez-Pérez S et al. Variation of central corneal thickness in diabetic patients as detected by ultrasonic pachymetry. Arch Soc Esp Oftalmol 2006; 81: 523-6.
40. Larsson L, Bourne W, Pach J, Brubaker R. Structural and function of the corneal endothelium in diabetes mellitus type I and type II. Arch Ophthalmol 1996; 114: 9-14.
41. Busted N, Olsen T, Schmitz O Clinical observation on the corneal thickness and the corneal endothelium in diabetes mellitus Br J Ophthalmol 1981; 65: 687-90.
42. Oriowo O. Profile of central corneal thickness in diabetics with and without dry eye in a Saudi population Optometry. Optometry Volume 2009; 80: 442-6.
43. Bierhaus A, Hofmann M, Zeigler R, Nawroth P. AGEs and their interaction with AGE-receptors in vascular disease and diabetes mellitus I. The AGE concept. Cardivasc Res 1998; 37: 586-600.
44. Yanagiya N, Akiba J, Kado M, et al. Transient corneal edema induced by nitric oxide synthase inhibition. Nitric Oxide 1997; 1: 397-403.
45. Wigham C, Guggenheim J, Hodson S. Sodium movement into and out of corneal endothelium. Pflugers Arch 1994; 428: 577-82.
46. Busted N, Olsen T, Schmitz O. Clinical observations on corneal thickness and the corneal endothelium in diabetes mellitus. Br J Ophthalmol 1981; 65: 687-90.
47. O'Donnell C, Efron N. Corneal endothelial cell morphometry and corneal thickness in diabetic contact lens wearers. Optom Vis Sci 2004; 81: 858-62.
48. Meyer LA, Ubels JL, Edelhauser HF. Corneal endothelial morphology in the rat. Invest Ophthalmol Vis Sci 1988; 29: 940-8.
49. Yee R, Matsuda M, Kern T, Engerman R, Edelhauser H. Corneal endothelial changes in diabetic dogs. Curr Eye Res 1985; 4: 759-66.
50. Inoue K, Kato S, Inoue Y, Amano S, Oshika T. The corneal endothelium an thickness in type II diabetes mellitus. Jpn J Ohthalmol 2002; 46: 65-9.
51. Shenoy R, Khandekar R, Bialasiewicz A, Muniri A. Corneal endothelium in patients with diabetes mellitus: a historical cohort study Eur J Ophthalmol 2009; 19: 369-75.
52. Lee J, Oum B, Choi H, Lee J, Cho B. Differences in corneal thickness and corneal endothelium related to duration in diabetes. Eye 2006; 20: 315-8.
53. Keoleian G, Pach J, Hodge D, Trocme S, Bourne W. Structural and functional studies of the cornela endothelium and diabetes mellitus Am J Ophthalmol 1992; 113: 64-70.
54. Ziadi M, Moiroux P, d'Athis P, Bron A, Brun JM, Creuzot-Garcher C. Assessment of induced corneal hypoxia in diabetic patients. Cornea 2002; 21: 453-7
55. Dogru M, Katakami C, Inoue M. Tear function and ocular surface changes in noninsulin-dependent diabetes mellitus. Ophthalmology 2001; 108: 586-92.
56. Schultz RO, Van Horn DL, Peters MA, Klewin KM, Schutten WH. Diabetic keratopathy. Trans Am Ophthalmol Soc 1981; 79: 180-99.
57. Cisarik-Fredenburg P. Discoveries in research on diabetic keratopathy. Optometry 2001; 72: 691-704.
58. Mackie I. Current ocular therapy. In: Fraunfelder F, Roy F, Eds. Current Ocular Therapy, 4th ed.: Philadelphia: WB Saunders 1995: pp. 506-8.
59. Morikubo S, Takamura Y, Kubo E, Tsuzuki S, Akagi Y. Corneal changes after small-incision cataract surgery in patients with diabetes mellitus Arch Ophthalmol 2004; 122: 966-9.
60. Halkiadakis I, Belfair N, Gimbel H. Laser in situ keratomileusis in patient with diabetes J Cataract Refract Surg 2005; 31: 1895-8.
61. Fraunfelder F, Rich L. Laser assisted in situ keratomileusis complications in diabetes mellitus Cornea 2002; 2: 246-8.
62. Chung H, Tolentino F, Cajita V, Acosta J, Refojo MF. Reevaluation of corneal complications after closed vitrectomy. Arch Ophthalmol 1998; 106: 916-9.
63. Abrams G, Azen S, Barr C, et al. The incidence of corneal abnormalities in the silicone study: silicone study report. Arch Ophthalmol 1995; 113: 764-9.
64. Takeuchi K, Hori Y, Hayakawa T, et al. A case of an old woman with Sjogren's syndrome associated with insulin dependent diabetes mellitus. Ryumachi 1996; 36: 769-74.
65. Kiritoshi A, SundarRaj N, Thoft RA. Differentiation in cultured limbal epithelium as defined by keratin expression. Invest Ophthalmol Vis Sci 1991; 32: 3073-7.
66. Schultz G, Davis J, Eiferman R. Growth factors and corneal epithelium. Cornea 1990; 9: 2-9.
67. Nagano T, Nakamura M, Nakata K. Effects of substance P and IGF-1 in cornea epithelial barrier function and wound healing in a rat model of neurotrophic keratopathy. Invest Ophthalmol Vis Sci 2002; 44: 3810-15.
68. Maldonado B, Furcht L. Epidermal growth factor stimulates integrin mediated cell migration of cultured human corneal epithelial cells on fibronectin and arginine-glycine-aspartic acid peptide. Invest Ophthalmol Vis Sci 1995; 36: 2120-6
69. Nishida T, Nakamura M, Mishima H, Otori T. Interleukin 6 promotes epithelial migration by a fibronectin-dependent mechanism. J Cell Physiol 1992; 153: 1-5.
70. David T, Rieck P, Renard G, Hartmann C, Courtois Y, Pouliquen Y. Corneal wound healing modulation using basic fibroblast growth factor after excimer laser photorefractive keratectomy. Cornea 1995; 14: 227-34.
71. Saika S, Okada Y, Miyamoto T. Role of p38 MAP kinase in regulation of cell migration and proliferation in healing corneal epithelium. Invest Ophthalmol Vis Sci 2004; 45: 100-9.
72. Sharma G, He J, Bazan H. p38 and ERK1/2 coordinate cellular migration and proliferation in epithelial wound healing. J Biol Chem 2003; 278: 21989-97.
73. Wilson S, Walker J, Chwang E, He Y. Hepatocyte growth factor, keratinocyte growth factor, their receptors, fibroblast growth factor receptor-2, and the cells of the cornea. Invest Ophthalmol Vis Sci 1993; 34: 2544-61.
74. Zagon I, Sassani J, McLaughlin P. Insulin treatment ameliorate impaired corneal reepithelization in diabetic rats. Diabetes 2006; 55: 1141-7.
75. McAvoy J, Chamberlain C. Growth factors in the eye. Prog Growth Factor Res 1990; 2: 29-43.
76. Benoliel A, Kahn-Perles B, Imbert J, Verrando P. Insulin stimulates haptotactic migration of human epidermal keratinocytes through activation of NF-kappa B transcription factor. J Cell Sci 1987; 110: 2089-97.
77. Rosenthal S. Acceleration of primary wound healing by insulin. Arch Surg 1968; 96: 53-5.
78. Van Ort S, Gerber R. Topical application of insulin in the treatment of decubitus ulcers: a pilot study. Nurs Res 1976; 25: 9-12.
79. Naeser P. Insulin receptors in human ocular tissues. Immunohistochemical demonstration in normal and diabetic eyes. Ups J Med Sci 1997; 102: 35-40.
80. Thomopoulos P, Pessac B. Insulin receptors in cultured mouse retinal cells. Diabetologia 1979; 16: 275-9.
81. Zagon I, Klocek M, Sassani J, McLaughlin P. Use of topical insulin to normalize corneal epithelial healing in diabetes mellitus. Arch Ophthalmol 2007; 125: 1082-8.
82. Ohashi Y, Matsuda M, Hosotani H. Aldose reductase inhibitor (CT-112) eye drops for diabetic corneal epitheliopathy. Am J Ophthalmol 1988; 105: 233-8.
83. Yokoi N, Niiya A, Komuro A. Effects of aldose reductase inhibitor, CT-112, on the corneal epithelial barrier of galactose-fed rats. Curr Eye Res 1997; 16: 595-9.
84. Abdelkader H, Dipika V, Patel D, et al. New therapeutic approaches in the treatment of diabetic keratopathy: a review Clin Exp Ophthalmol 2011; 39: 259-70.
85. Kubo E, Nakamura S, Tsuzuki S, et al. Inhibitory effect of orally administered aldose reductase inhibitor SNK-860 on corneal polyol accumulation in galactose-fed rats Graeffes Archives of Clin Exp Ophthalmology 1999; 9: 758-62.
86. Nakahara M, Miyata K, Otani S, et al. A randomised, placebo controlled clinical trial of the aldose reductase inhibitor CT-112 as management of corneal epithelial disorders in diabetic patients Br J Ophthalmol 2005; 3: 266-8.
87. Denison F, Kelly R, Calder A, Riley S. Cytokine secretion by human fetal membranes, decidua and placenta at term. Hum Reprod 1998; 12: 3560-5.
88. Nguyen P, Khashabi S, Yiu S. Ocular Surface Reconstitution, Progress in Molecular and Environmental Bioengineering. In: Carpi A, Ed. Analysis and Modeling to Technology Applications, InTech. 2011 pp.291-322.
89. Koizumi N, Inatomi T, Quantock A, Fullwood N, Dota A, Kinoshita S. Amniotic membrane as a substrate for cultivating limbal corneal epithelial cells for autologous transplantation in rabbits. Cornea 2000; 1: 65-71.
90. Kim J, Kim JC, Na B, Jeong J, Song C. Amniotic membrane patching promotes healing and inhibits proteinase activity on wound healing following acute corneal alkali burn. Exp Eye Res 2000; 3: 329-37.
91. Girolamo D, Chui N, Wakefield J, Coroneo D. Cultured human ocular surface epithelium on therapeutic contact lenses. British J Ophthalmol 2007; 4: 459-464.
92. Deshpande P, Notara M, Bullett N, Daniels J, Haddow D, Macneil S. Development of a Surface-Modified Contact Lens for the Transfer of Cultured Limbal Epithelial Cells to the Cornea for Ocular Surface Diseases. Tissue Eng A 2009; 10 2889-902.
93. Kim J, Kim C, Kim H, et al. Protection against advanced glycation end products and oxidative stress during the development of diabetic keratopathy by KIOM-79. J Pharm Pharmacol 2011; 63: 524-30.
94. Ho J, Su Y, Chen K, Lee O. Protection of Thymosin Beta-4 on Corneal Endothelial Cells from UVB-Induced Apoptosis. Chin J Physiol 2010; 53: 190-5.
95. Ho J, Chuang C, Ho C, Shih Y, Lee O, Su Y. Internalization is essential for the antiapoptotic effects of exogenous thymosin beta-4 on human corneal epithelial cells. Invest Ophthalmol Vis Sci 2007; 48: 27-33.
96. Bourne W, Nelson L, Hodge D. Central corneal endothelial cell changes over a ten-year period. Invest Ophthalmol Vis Sci 1997; 38: 779-82.
97. Joyce N, Harris D, Mello D. Mechanisms of mitotic inhibition in corneal endothelium: contact inhibition and TGF-beta 2. Invest Ophthalmol Vis Sci 2002; 43: 2152-9.
98. Peh G, Beuerman R, Colman A, Tan D, Mehta J. Human Corneal Endothelial Cell Expansion for Corneal Endothelium Transplantation: An Overview Transplantation 2011; 91: 811-9.
99. Lu X, Chen D, Liu Z, et al. Enhanced survival in vitro of human corneal endothelial cells using mouse embryonic stem cell conditioned medium Mol Vis 2010; 16: 611-22.
100. Yamaguchi M, Ebihara N, Shima N, et al. Adhesion, Migration, and Proliferation of Cultured Human Corneal Endothelial Cells by Laminin-5. Invest Ophthalmol Vis Sci 2011; 52: 679-84.
101. Jun A, Larkin D. Prospects for gene therapy in corneal disease. Eye 2003; 17: 906-11.
102. Gonga N, Eckec I, Merglera S, et al. Gene transfer of cytoprotective molecules in corneal endothelial cells and cultured corneas: Analysis of protective effects in vitro and in vivo. Biochem and Biophys Res Commun 2007; 357: 302-7.
103. Fuchsluger T, Jurkunas U, Kazlauskas A, Dana R. Anti-apoptotic gene therapy prolongs survival of corneal endothelial cells during storage. Gene Ther 2011; 8: 778-87.
104. Fernandez M, Afshari N. Endothelial keratoplasty: from DLEK to DMEK. Middle East Afr J Ophthalmol. 2010; 1: 5-8.
105. Neff K, Biber J, Holland E. Comparison of central corneal graft thickness to visual acuity outcomes in endothelial keratoplasty. Cornea. 2011; 4: 388-391.
106. Tillet C. Posterior lamellar keratoplasty. Am J Ophthalmol. 1956; 41: 530-533.
107. Melles G, Eggink F, Lander F, et al. A surgical technique for posterior lamellar keratoplasty. Cornea 1998; 17: 618-26.
108. Terry M, Ousley P. Endothelial replacement without surface corneal incisions or sutures: topography of the deep lamellar endothelial keratoplasty procedure. Cornea. 2001; 20: 14-18.
109. Melles G, Wijdh R, Nieuwendaal C. A technique to excise the Descemet membrane from a recipient cornea (descemetorhexis). Cornea. 2004; 23: 286-8.
110. Gorovoy M. Descemet-stripping automated endothelial keratoplasty (DSAEK). Cornea 2006; 8: 886-9.
111. Price M, Bidros M, Gorovoy M, et al. Effect on incision width on graft survival and endothelial cell loss after Descemet stripping automated endothelial keratoplasty. Cornea 2010; 5: 523-7.
112. Cisarik-Fredenburg P. Discoveries in research on diabetic keratopathy. Optometry 2001; 72: 691-704.